Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Regul Homeost Agents ; 31(1): 77-80, 2017.
Article in English | MEDLINE | ID: mdl-28337873

ABSTRACT

Cyclosporine-A induces gingival overgrowth with disturbance in the homeostasis of cells and connective tissue proteins. Human gingival fibroblasts were cultured with cyclosporine A, and the expression of two vital endoplasmic stress markers and two prime matrix proteins (connective tissue growth factor (CTGF and periostin) were assessed by RT-PCR. We found that expression of Glucose-Regulated Protein 78 (GRP78/BIP) and CCAAT/enhancer binding protein, C/EBP homologous protein (CHOP) were significantly increased, along with CTGF and periostin, suggesting a role for these factors in gingival overgrowth.


Subject(s)
Cell Adhesion Molecules/genetics , Connective Tissue Growth Factor/genetics , Cyclosporine/adverse effects , Endoplasmic Reticulum Stress/drug effects , Heat-Shock Proteins/genetics , Immunosuppressive Agents/adverse effects , Transcription Factor CHOP/genetics , Biomarkers/metabolism , Cell Adhesion Molecules/agonists , Cell Adhesion Molecules/metabolism , Connective Tissue Growth Factor/agonists , Connective Tissue Growth Factor/metabolism , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Chaperone BiP , Endoplasmic Reticulum Stress/genetics , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Expression Regulation , Gingiva/cytology , Gingiva/drug effects , Gingiva/metabolism , Heat-Shock Proteins/agonists , Heat-Shock Proteins/metabolism , Humans , Primary Cell Culture , Signal Transduction , Transcription Factor CHOP/agonists , Transcription Factor CHOP/metabolism
2.
J Cardiovasc Pharmacol ; 67(2): 110-20, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26371948

ABSTRACT

Connective tissue growth factor (CTGF) is a fibrogenic cytokine that promotes fibrosis in various organs. In the heart, both cardiomyocytes (CM) and cardiac fibroblasts have been reported as a source of CTGF expression, aiding cardiac fibrosis. Although the mammalian target of rapamycin (mTOR) forms 2 distinct complexes, mTORC1 and mTORC2, and plays a central role in integrating biochemical signals for protein synthesis and cellular homeostasis, we explored its role in CTGF expression in adult feline CM. CM were stimulated with 10 µM phenylephrine (PE), 200 nM angiotensin (Ang), or 100 nM insulin for 24 hours. PE and Ang, but not insulin, caused an increase in CTGF mRNA expression with the highest expression observed with PE. Inhibition of mTOR with torin1 but not rapamycin significantly enhanced PE-stimulated CTGF expression. Furthermore, silencing of raptor and rictor using shRNA adenoviral vectors to suppress mTORC1 and mTORC2, respectively, or blocking phosphatidylinositol 3-kinase (PI3K) signaling with LY294002 (LY) or Akt signaling by dominant-negative Akt expression caused a substantial increase in PE-stimulated CTGF expression as measured by both mRNA and secreted protein levels. However, studies with dominant-negative delta isoform of protein kinase C demonstrate that delta isoform of protein kinase C is required for both agonist-induced CTGF expression and mTORC2/Akt-mediated CTGF suppression. Finally, PE-stimulated CTGF expression was accompanied with a corresponding increase in Smad3 phosphorylation and pretreatment of cells with SIS3, a Smad3 specific inhibitor, partially blocked the PE-stimulated CTGF expression. Therefore, a PI3K/mTOR/Akt axis plays a suppressive role on agonist-stimulated CTGF expression where the loss of this mechanism could be a contributing factor for the onset of cardiac fibrosis in the hypertrophying myocardium.


Subject(s)
Connective Tissue Growth Factor/agonists , Connective Tissue Growth Factor/biosynthesis , Myocytes, Cardiac/metabolism , TOR Serine-Threonine Kinases/biosynthesis , Angiotensins/pharmacology , Animals , Cats , Cells, Cultured , Myocytes, Cardiac/drug effects , Phenylephrine/pharmacology
3.
Nat Commun ; 5: 5797, 2014 Dec 12.
Article in English | MEDLINE | ID: mdl-25504335

ABSTRACT

Systemic sclerosis (SSc) is manifested by fibrosis, vasculopathy and immune dysregulation. So far, a unifying hypothesis underpinning these pathological events remains unknown. Given that SSc is a multifactorial disease caused by both genetic and environmental factors, we focus on the two transcription factors, which modulate the fibrotic reaction and are epigenetically suppressed in SSc dermal fibroblasts, Friend leukaemia integration 1 (Fli1) and Krüppel-like factor 5 (KLF5). In addition to the Fli1 silencing-dependent collagen induction, the simultaneous knockdown of Fli1 and KLF5 synergistically enhances expression of connective tissue growth factor. Notably, mice with double heterozygous deficiency of Klf5 and Fli1 mimicking the epigenetic phenotype of SSc skin spontaneously recapitulate all the three features of SSc, including fibrosis and vasculopathy of the skin and lung, B-cell activation and autoantibody production. These studies implicate the epigenetic downregulation of Fli1 and KLF5 as a central event triggering the pathogenic triad of SSc.


Subject(s)
Autoantibodies/biosynthesis , B-Lymphocytes/metabolism , Kruppel-Like Transcription Factors/genetics , Proto-Oncogene Protein c-fli-1/genetics , Scleroderma, Systemic/genetics , Skin/metabolism , Animals , Autoimmunity , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Blood Vessels/immunology , Blood Vessels/metabolism , Blood Vessels/pathology , Case-Control Studies , Collagen/agonists , Collagen/genetics , Collagen/immunology , Connective Tissue Growth Factor/agonists , Connective Tissue Growth Factor/genetics , Connective Tissue Growth Factor/immunology , Disease Models, Animal , Epigenesis, Genetic , Fibroblasts/immunology , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis , Humans , Kruppel-Like Transcription Factors/antagonists & inhibitors , Kruppel-Like Transcription Factors/immunology , Lung/immunology , Lung/metabolism , Lung/pathology , Lymphocyte Activation , Mice , Mice, Transgenic , Proto-Oncogene Protein c-fli-1/antagonists & inhibitors , Proto-Oncogene Protein c-fli-1/immunology , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Scleroderma, Systemic/immunology , Scleroderma, Systemic/metabolism , Scleroderma, Systemic/pathology , Signal Transduction , Skin/immunology , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...